Courtesy of Benzinga.
Analysts at Morgan Stanley downgraded Mindray Medical International (NYSE: MR) from Equal-weight to Underweight.
The price target for Mindray Medical has been lowered from $37 to $28.
Mindray Medical shares have declined 24.02% over the past 52 weeks, while the S&P 500 index has gained 14.65% in the same period.
Mindray Medical’s shares fell 0.28% to close at $28.19 yesterday.
Latest Ratings for MR
Date | Firm | Action | From | To |
---|---|---|---|---|
Dec 2014 | Morgan Stanley | Downgrades | Equal-weight | Underweight |
May 2014 | Jefferies | Assumes | Hold | |
May 2014 | Bank of America | Downgrades | Buy | Neutral |
View More Analyst Ratings for MR
View the Latest Analyst Ratings
Posted-In: Morgan StanleyDowngrades Analyst Ratings